Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRANEXAMIC ACID vs TRASTUZUMAB DERUXTECAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRANEXAMIC ACID vs TRASTUZUMAB DERUXTECAN: Safety Overview

Metric TRANEXAMIC ACID TRASTUZUMAB DERUXTECAN
Total FAERS Reports 3,099 2,684
Deaths Reported 319 653
Death Rate 10.3% 24.3%
Hospitalizations 1,225 780
Average Patient Age 49.3 yrs 56.5 yrs
% Female Patients 61.7% 91.9%
FDA Approval Date Apr 15, 2019 N/A
Manufacturer Nordic Pharma, Inc. Daiichi Sankyo Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued N/A